Genflow Biosciences plc (GENFF)

Market Cap	3.97M
Revenue (ttm)	n/a
Net Income (ttm)	-1.99M
Shares Out	n/a
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,168
Open	0.0150
Previous Close	0.0150
Day's Range	0.0150 - 0.0150
52-Week Range	0.0100 - 0.0605
Beta	2.17
RSI	63.93
Earnings Date	Sep 26, 2025

About Genflow Biosciences

Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for in...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2020
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: GENFF

Financial Performance

Financial numbers in GBP